FDA.reportPublic FDA data

Livmarli 20 MG Oral Tablet

RxCUI
2712471
RxNorm name
Livmarli 20 MG Oral Tablet
Display name
Livmarli 20 MG Oral Tablet
Full name
Livmarli 20 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LivmarliMARALIXIBAT CHLORIDEMirum Pharmaceuticals Inc.64000394-1ef6-4e76-8ba8-11f25ba1b1672025-04-10Warnings, Adverse reactionsExact identifier
rxcui: 2712471

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
64000394-1ef6-4e76-8ba8-11f25ba1b167Livmarli 20 MG Oral Tablet [PSN] · maralixibat 20 MG Oral Tablet [Livmarli] [SBD] · Livmarli 20 MG (equivalent to maralixibat chloride 21 MG) Oral Tablet [SY] · Livmarli 20 MG Oral Tablet [SY]411These highlights do not include all the information needed to use LIVMARLI safely and effectively. See full prescribing information for LIVMARLI. LIVMARLI ® (maralixibat) oral solution LIVMARLI ® (maralixibat) tablets, for oral use Initial U.S. Approval: 202120250410